Fontinha, B M <br/><br/>
Enhancement of long-term potentiation by brain-derived neurotrophic factor requires adenosine A2A receptor activation by endogenous adenosine.  [electronic resource] 

 -  Neuropharmacology  May 2008 
 - 924-33 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0028-3908 
<br/><br/><label>Standard No.: </label>10.1016/j.neuropharm.2008.01.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine--analogs & derivatives<br/>Adenosine A2 Receptor Agonists<br/>Adenosine A2 Receptor Antagonists<br/>Animals<br/>Brain-Derived Neurotrophic Factor--pharmacology<br/>Carbazoles--pharmacology<br/>Cyclic AMP--physiology<br/>Cyclic AMP-Dependent Protein Kinases--antagonists & inhibitors<br/>Data Interpretation, Statistical<br/>Excitatory Postsynaptic Potentials--drug effects<br/>Hippocampus--drug effects<br/>In Vitro Techniques<br/>Indole Alkaloids--pharmacology<br/>Isoquinolines--pharmacology<br/>Long-Term Potentiation--drug effects<br/>Male<br/>Neuroprotective Agents--pharmacology<br/>Phenethylamines--pharmacology<br/>Phosphorylation--drug effects<br/>Pyrimidines--pharmacology<br/>Rats<br/>Rats, Wistar<br/>Receptor, Adenosine A2A--physiology<br/>Sulfonamides--pharmacology<br/>Triazoles--pharmacology